DOI: 10.1128/JCM.01865-16
Article Information
PubMed
Published By
History
- Received September 8, 2016
- Returned for modification November 9, 2016
- Accepted December 9, 2016
- Published online February 22, 2017.
Copyright & Usage
Copyright © 2017 American Society for Microbiology.
All Rights Reserved
.
Editors and / or Reviewers
- Geoffrey A. Land, Editor, Carter BloodCare & Baylor University Medical Center
Article Versions
- Accepted Manuscript version (December 14, 2016).
- You are viewing the most recent version of this article.
Author Information
- Y. Gardeea,b,
- A. W. Dreyerb,
- H. J. Koornhofa,b,
- S. V. Omara,
- P. da Silvab,d,
- Z. Bhyata and
- N. A. Ismaila,c
- aCentre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa
- bDepartment of Clinical Microbiology and Infectious Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- cDepartment of Medical Microbiology, Faculty of Health Science, University of Pretoria, Pretoria, South Africa
- dNational Health Laboratory Service, Mycobacterial Referral Laboratory, Braamfontein, Johannesburg, South Africa
- Address correspondence to Y. Gardee, yasming{at}nicd.ac.za.
Citation Gardee Y, Dreyer AW, Koornhof HJ, Omar SV, da Silva P, Bhyat Z, Ismail NA. 2017. Evaluation of the genotype MTBDRsl version 2.0 assay for second-line drug resistance detection of Mycobacterium tuberculosis isolates in South Africa. J Clin Microbiol 55:791–800. https://doi.org/10.1128/JCM.01865-16 .
